Amardeep S. Grewal, MD
About Dr. Grewal
Licensure
State of Pennsylvania Unrestricted Medical License
Drug Enforcement Agency Controlled Substance License
Professional Organizations
American Society for Radiation Oncology (ASTRO)
American Society of Clinical Oncology (ASCO)
Awards & Affiliations
Education
Harvard University
2007 - 2010
Cambridge, Massachusetts
Bachelor of Arts in Molecular & Cellular Biology, Minor in Economics
Harvard Medical School
2011 - 2015
Boston, Massachusetts
Doctor of Medicine
University of Pennsylvania
2015 - 2016
Philadelphia, Pennsylvania
Internship in Internal Medicine
University of Pennsylvania
2016 - 2020
Philadelphia, Pennsylvania
Residency, Radiation Oncology Elected Chief Resident during PGY4 and PGY5 years
Employment
Research Associate, Center for Digital Health, University of Pennsylvania
2019 - 2019
Philadelphia, Pennsylvania
Clinical Research Coordinator & Decision Support Services Intern, UCSF Breast Care Center
Publications
Find Dr. Grewel’s full list of publications on PubMed here.
- Grewal AS, Padera RF, Boukedes S, Divo M, Rosas IO, Camp PC, Fuhlbrigge A, Goldberg H, El-Chemaly S. Prevalence and outcome of lung cancer in lung transplant recipients. Respir Med 2015; 109(3): 427-33.
- Yammine M, Neely RC, Loberman D, Rajab TK, Grewal AS, McGurk S, Fitzgerald D, Aranki SF. The Use of Lidocaine Containing Cardioplegia in Surgery for Adult Acquired Heart Disease. J Card Surg 2015; 30(9): 677-84.
- Grewal AS, Freedman GM, Jones JA, Taunk NK. Hypofractionated radiation therapy for durable palliative treatment of bleeding, fungating breast cancers. Pract Radiat Oncol 2019; 9(2):73-6.
- Grewal AS, Jones JJ, Lin A. Palliative radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2019 In press.
- Grewal AS, Schonewolf C, Min EJ, Chao HH, Both S, Lam S, Mazzoni S, Bekelman J, Christodouleas J, Vapiwala N. Four-year outcomes of hypofractionated proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2019 In press.
- Grewal AS, Rajasekaran K, Cannady SB, Chalian AA, Ghiam AF, Lin A, liVolsi V, Lukens JN, Mitra N, Montone KT, Newman JG, O’Malley Jr, BW, Rassekh CH, Weinstein GS, Swisher-McClure S. Pharyngeal Sparing Radiation for Head and Neck Carcinoma of Unknown Primary following TORS assisted work-up. Laryngoscope. 2019 In press.
- Grewal AS, Berman AT. Patient Reported Outcomes and Quality of Life in Radiation Oncology. Clinics Hematology & Oncology. 2019 In press.
Selected Meeting Presentations
- Grewal AS, Padera RF, Boukedes S, Divo M, Rosas IO, Camp PC, Fuhlbrigge A, Goldberg H, El-Chemaly S. Prevalence and outcome of lung cancer in lung transplant recipients. Accepted for Poster Presentation. American Thoracic Society Annual Meeting. Philadelphia, Pennsylvania. May 2013.
- Grewal AS, Ben Josef, E. SMAD4 mutation acquisition in the metastatic transformation of pancreatic cancer. Accepted for Poster Presentation. GI ASCO Meeting. San Francisco, California. January 2018.
- Grewal AS, Ben Josef, E. SMAD4 mutations predictive of metastatic disease. Accepted for Oral Presentation. American College of Radiation Oncology Annual Meeting. Ft. Lauderdale, Florida. February 2018.
- Grewal AS, Li Y, Fisher MJ, Minturn J, Belasco J, Phillips P, Kang T, Lustig R, HillKayser C. Primary Site Irradiation using Proton Therapy in Young Children with Medulloblastoma. Accepted for Poster Discussion. ASTRO 2018 Annual Meeting. San Antonio, Texas. October 2018.Status: Manuscript submitted
- Grewal AS, Schonewolf C, Min EJ, Chao HH, Both S, Lam S, Mazzoni S, Bekelman J, Christodouleas J, Vapiwala N. Four-year outcomes of hypofractionated proton therapy for localized prostate cancer. Accepted for Poster Presentation. GU ASCO Meeting. San Francisco, California. February 2019.
- Grewal AS, Schonewolf C, Min EJ, Chao HH, Both S, Lam S, Mazzoni S, Bekelman J, Christodouleas J, Vapiwala N. Four-year outcomes of hypofractionated proton therapy for localized prostate cancer. Accepted for Poster Presentation. GU ASCO Meeting. San Francisco, California. February 2019.Status: Accepted; in press
- Grewal AS, Gabriel P, Doucette A, Metz J, Wojcieszynski A. The Use of Patient Reported Outcomes to Predict Unplanned Inpatient Hospitalizations and Emergency Department Visits in Cancer Patients Receiving Concurrent Chemotherapy and Radiation Therapy. Accepted for Oral Presentation. American Radium Society Annual Meeting. Los Angeles, California. April 2019.
Status: Manuscript submitted - Grewal AS, Rajasekaran K, Cannady SB, Chalian AA, Ghiam AF, Lin A, liVolsi V, Lukens JN, Mitra N, Montone KT, Newman JG, O’Malley Jr, BW, Rassekh CH,
Weinstein GS, Swisher-McClure S. Pharyngeal Sparing Radiation for Head and Neck Carcinoma of Unknown Primary following TORS assisted work-up. Accepted for Poster Presentation. AHNS 2019 Annual Meeting. Austin, Texas. May 2019.
Status: Accepted; in press - Grewal AS, Min EJ, Long Q, Grewal SK, Jain V, Levin WP, Cengel KA, SwisherMcClure S, Aggarwal C, Bauml JM, Singh A, Ciunci C, Cohen RB, Langer C, Feigenberg SJ, Berman AT. Early Tumor and Nodal Response in Patients with Locally-advanced NSCLC Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and chemotherapy. Accepted for Oral Presentation. ASTRO 2019 Annual Meeting. Chicago, Illinois. September 2019.
Status: Manuscript submitted - Grewal AS, Li Y, Grewal SK, Bagatell R, Balamuth N, Womer R, Kurtz G, Tochner Z, Hill-Kayser C. Role of metastatic site irradiation in pediatric patients with metastatic Ewing Sarcoma. Accepted for Poster Presentation. ASTRO 2019 Annual Meeting. Chicago, Illinois. September 2019.
Status: Manuscript submitted - Role of metastatic site irradiation in pediatric patients with metastatic Ewing Sarcoma. Accepted for Poster Presentation. ASTRO 2019 Annual Meeting. Chicago, Illinois. September 2019.
Status: Manuscript submitted
